IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Covidien reports rise in API sales

7:11 AM MDT | April 29, 2013 | Deepti Ramesh

The active pharmaceutical ingredient (API) business of Covidien (Dublin) report an 11.4% rise in sales in the company’s second quarter, ended 29 March, compared with the year-ago quarter, to $127 million. Sales of APIs were considerably higher than the previous year, largely attributable to a substantial increase in sales of narcotic API products, Covidien says. During the 6-month period ended 29 March, the API business reported a 1.8% rise in sales compared with the corresponding period of the previous fiscal year, to $220...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa